607 related articles for article (PubMed ID: 16248213)
1. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report.
Kar BR; Job CK
Lepr Rev; 2005 Sep; 76(3):258-62. PubMed ID: 16248213
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
4. Positive Mitsuda lepromin reactions in long-term treated lepromatous leprosy.
Waters MF; Ridley DS; Lucas SB
Lepr Rev; 1990 Dec; 61(4):347-52. PubMed ID: 2280656
[TBL] [Abstract][Full Text] [Related]
5. Comment: Positive Mitsuda lepromin reaction in long-term treated lepromatous leprosy and tuberculoid relapse in lepromatous leprosy.
Walter J
Lepr Rev; 1991 Dec; 62(4):434-6. PubMed ID: 1845302
[No Abstract] [Full Text] [Related]
6. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
[TBL] [Abstract][Full Text] [Related]
7. A case of lepromatous leprosy with multiple relapses.
Hulmani M; Marne RB; Dandakeri S
Lepr Rev; 2009 Jun; 80(2):210-4. PubMed ID: 19743626
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
[TBL] [Abstract][Full Text] [Related]
9. Immunological upgrading with combined immunotherapy and chemotherapy in a lepromatous leprosy patient: a case report.
Zaheer SA; Suresh NR; Kar HK; Sharma AK; Mukherjee A; Mukherjee R; Talwar GP
Lepr Rev; 1991 Sep; 62(3):297-302. PubMed ID: 1795588
[TBL] [Abstract][Full Text] [Related]
10. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
11. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma.
Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450
[TBL] [Abstract][Full Text] [Related]
12. Tuberculoid relapse in lepromatous leprosy.
Waters MF; Ridley DS
Lepr Rev; 1990 Dec; 61(4):353-65. PubMed ID: 2280657
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
14. Silent iritis in treated bacillary negative leprosy.
Thompson K; Job CK
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
[TBL] [Abstract][Full Text] [Related]
15. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
[TBL] [Abstract][Full Text] [Related]
16. Epithelioid granuloma in the iris of a lepromatous leprosy patient; an unusual finding.
Daniel E; Ebenezer GJ; ffytche TJ; Sigamani A; Job CK
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):152-5. PubMed ID: 11036495
[TBL] [Abstract][Full Text] [Related]
17. BCG immunotherapy as an adjunct to chemotherapy in BL-lL patients--its effect on clinical regression, reaction severity, nerve function, lepromin conversion, bacterial/antigen clearance and 'persister' M. leprae.
Shetty VP; Mistry NF; Wakade AV; Ghate SD; Capadia GD; Pai VV
Lepr Rev; 2013 Mar; 84(1):23-40. PubMed ID: 23741880
[TBL] [Abstract][Full Text] [Related]
18. Relapse of lepromatous leprosy after WHO/MDT with rapid bacterial growth.
Oliveira ML; Pierro AP; Silveira PA; Campos MM; Vilela MF
Lepr Rev; 2002 Dec; 73(4):386-8. PubMed ID: 12549846
[TBL] [Abstract][Full Text] [Related]
19. Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships.
Alcaïs A; Sanchez FO; Thuc NV; Lap VD; Oberti J; Lagrange PH; Schurr E; Abel L
J Infect Dis; 2000 Jan; 181(1):302-8. PubMed ID: 10608779
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]